Fingerprint
Dive into the research topics of 'A phase 1/2 study of the combination of acalabrutinib and vistusertib in patients with relapsed/refractory B-cell malignancies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase 1/2 study of the combination of acalabrutinib and vistusertib in patients with relapsed/refractory B-cell malignancies
Graham P. Collins, Tracy N. Clevenger, Kathleen A. Burke, Buyue Yang, Alex MacDonald, David Cunningham, Christopher P. Fox, Andre Goy, John Gribben, Grzegorz S. Nowakowski, Mark Roschewski, Julie M. Vose, Anusha Vallurupalli, Jean Cheung, Amelia Raymond, Barrett Nuttall, Dan Stetson, Brian A. Dougherty, Stein Schalkwijk, Larissa S. Carnevalli
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations